You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Human Leukocyte Antigens

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Burns Trial (Skin allograft)

Withdrawn
  • Burns
  • Skin allograft
  • (no location specified)
Mar 16, 2021

Nanoparticle for DSA Removal

Recruiting
  • Kidney Failure
  • Presence of Donor Specific Antibodies
    • Zurich, ZH, Switzerland
      University Hospital Zurich, Division of Anaesthesiology
    Mar 11, 2022

    Antigens or Therapeutic Agents on in Vitro Human Intestinal

    Recruiting
    • Intestine Disease
      • Erlangen, Germany
        Department of Medicine 1, Hector Center for Nutrition, Exercise
      Jan 12, 2023

      Platelet Refractoriness, Hematologic Malignancy Trial in Charlottesville (isatuximab 10 mg/kg)

      Recruiting
      • Platelet Refractoriness
      • Hematologic Malignancy
      • isatuximab 10 mg/kg
      • Charlottesville, Virginia
        University of Virginia
      Jan 27, 2023

      Healthy, Latent Tuberculosis Infection (LTBI) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Tuberculin

      Recruiting
      • Healthy
      • Latent Tuberculosis Infection (LTBI)
      • Tuberculin Purified Protein Derivative
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jul 22, 2022

      Melanoma Trial in Germany (Lipo-MERIT)

      Active, not recruiting
      • Melanoma
      • Lipo-MERIT
      • Frankfurt, Germany
      • +3 more
      Jan 5, 2023

      Will Permit Sites to Proactively Assess TAA, HLA and HPV-16

      Terminated
      • Head and Neck Cancer
      • +7 more
      • Tumor Profiling
      • Scottsdale, Arizona
      • +2 more
      Dec 2, 2022

      Chronic Kidney Disease (CKD) Trial in New Haven, New York, Philadelphia (REGN5459, REGN5458)

      Not yet recruiting
      • Chronic Kidney Disease (CKD)
      • New York, New York
        New York University Langone Health - Transplant Institute
      Jul 11, 2022

      Human Leukocyte Antigen Typing and Tumor Antigen Expression

      Recruiting
      • Refractory Cancer
      • +3 more
        • Chicago, Illinois
        • +3 more
        Feb 14, 2022

        Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,

        Not yet recruiting
        • Head and Neck Cancer
        • +20 more
        • TSC-204-A0201
        • +4 more
        • Scottsdale, Arizona
        • +1 more
        Aug 3, 2023

        Monocyte Expression of Human Leukocyte Antigen - DR Isotype

        Recruiting
        • Critical Care
        • Blood sampling
        • Lyon, France
          Service de reanimation chirurgicale
        Oct 27, 2022

        Corticosteroids Induced Immunosuppression Using Monocyte Human

        Not yet recruiting
        • Immunosuppression
        • mHLA-DR
        • (no location specified)
        Jan 17, 2022

        Influenza Trial in Hollywood, Rochester, Mount Pleasant (Quadrivalent RIV with H3 strain 1, Quadrivalent RIV with H3 strain 2,

        Completed
        • Influenza
        • Quadrivalent RIV with H3 strain 1
        • +4 more
        • Hollywood, Florida
        • +2 more
        Apr 21, 2022

        Acute Respiratory Distress Syndrome Trial (Racecadotril 100 milligram (MG) Oral Capsule, Placebo)

        Not yet recruiting
        • Acute Respiratory Distress Syndrome
        • Racecadotril 100 milligram (MG) Oral Capsule
        • Placebo
        • (no location specified)
        Jan 13, 2023

        Kidney Transplant Rejection Trial (MDR-102, Immunosuppressive Agents)

        Not yet recruiting
        • Kidney Transplant Rejection
        • MDR-102
        • Immunosuppressive Agents
        • (no location specified)
        Apr 4, 2022

        Influenza Trial in United States (Quadrivalent RIV with H3 strain 1, Quadrivalent RIV with H3 strain 1 and adjuvant,

        Completed
        • Influenza
        • Quadrivalent RIV with H3 strain 1
        • +5 more
        • San Diego, California
        • +4 more
        Apr 21, 2022

        The Effect of Human Prostate Tissue on Platelet Activation

        Completed
        • Prostate Hyperplasia
        • +2 more
          • (no location specified)
          Sep 19, 2021

          Subclass of Donor-specific Antibody asRisk Factor of Antibody

          Active, not recruiting
          • Antibody-mediated Rejection
            • Montpellier, Hérault, France
              CHU Lapeyronie
            Jan 18, 2023

            Postoperative Infectious Complications in Colorectal Cancer

            Completed
            • Colorectal Cancer
              • Moscow, Russian Federation
                State Scientific Centre of Coloproctology
              Sep 21, 2021

              Ewing Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma Trial in Frankfurt am Main, Freiburg, Tübingen (Peptide vaccine IPX)

              Recruiting
              • Ewing Sarcoma
              • +2 more
              • Peptide vaccine IPX
              • Frankfurt am Main, Germany
              • +2 more
              Oct 18, 2023

              End Stage Renal Disease Trial in Los Angeles (Tacrolimus Extended-Release Oral Capsule)

              Completed
              Has Results
              • End Stage Renal Disease
              • Tacrolimus Extended-Release Oral Capsule
              • Los Angeles, California
                Cedars Sinai Medical Center
              Jan 7, 2022

              Ependymoma Trial in Pittsburgh (biological, drug, other)

              Recruiting
              • Ependymoma
              • HLA-A2 restricted synthetic tumor antigen
              • +5 more
              • Pittsburgh, Pennsylvania
                Children's Hospital of Pittsburgh of UPMC
              Oct 23, 2022

              Hematologic Malignancies Trial in La Jolla (Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant)

              Suspended
              • Hematologic Malignancies
              • Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant
              • La Jolla, California
                UCSD Medical Center
              Jul 20, 2022

              Shigellosis Trial in Baltimore (S. sonnei 53G, S. flexneri 2a 2457T)

              Recruiting
              • Shigellosis
              • S. sonnei 53G
              • S. flexneri 2a 2457T
              • Baltimore, Maryland
                Center for Immunization Research (CIR) at Johns Hopkins School o
              Dec 15, 2021

              Inflammatory and Anti-Inflammatory Gene Expressions in Liver

              Active, not recruiting
              • Liver Transplant; Complications
              • +3 more
              • Molecular Immunology , gene expressions
              • Malatya, Turkey
                İnönü University
              May 2, 2023